ADVENT SOFTWARE INC /DE/ 4
4 · ADVENT SOFTWARE INC /DE/ · Filed Jul 12, 2013
Insider Transaction Report
Form 4
Manfredi Christine S
Director
Transactions
- Disposition to Issuer
Stock Appreciation Rights
2013-07-10−42,000→ 0 totalExercise: $15.72From: 2010-03-23Exp: 2019-03-23→ Common Stock (42,000 underlying) - Award
Stock Appreciation Rights
2013-07-10+42,000→ 42,000 totalExercise: $7.84From: 2010-03-23Exp: 2019-03-23→ Common Stock (42,000 underlying) - Award
Stock Appreciation Rights
2013-07-10+9,814→ 9,814 totalExercise: $21.06From: 2014-05-09Exp: 2023-05-09→ Common Stock (9,814 underlying) - Disposition to Issuer
Stock Appreciation Rights
2013-07-10−8,470→ 0 totalExercise: $26.80From: 2013-05-09Exp: 2022-05-09→ Common Stock (8,470 underlying) - Award
Stock Appreciation Rights
2013-07-10+8,925→ 8,925 totalExercise: $17.49From: 2012-05-11Exp: 2021-05-11→ Common Stock (8,925 underlying) - Award
Stock Appreciation Rights
2013-07-10+10,000→ 10,000 totalExercise: $12.34From: 2011-06-02Exp: 2020-06-02→ Common Stock (10,000 underlying) - Award
Stock Appreciation Rights
2013-07-10+8,470→ 8,470 totalExercise: $17.80From: 2013-05-09Exp: 2022-05-09→ Common Stock (8,470 underlying) - Disposition to Issuer
Stock Appreciation Rights
2013-07-10−10,000→ 0 totalExercise: $21.34From: 2011-06-02Exp: 2020-06-02→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Appreciation Rights
2013-07-10−8,925→ 0 totalExercise: $26.49From: 2012-05-11Exp: 2021-05-11→ Common Stock (8,925 underlying) - Disposition to Issuer
Stock Appreciation Rights
2013-07-10−9,814→ 0 totalExercise: $30.06From: 2014-05-09Exp: 2023-05-09→ Common Stock (9,814 underlying)
Footnotes (1)
- [F1]The transactions reported on this Form 4 reflect an amendment to outstanding options. The Company modified its outstanding stock option awards by reducing the exercise price by $9 per option. For certain options that cannot be reduced by the full $9, Advent compensated those option holders with a cash payment for the difference between $9 and the reduction of their exercise price. No other change to original terms of grant, no market activity.